Last reviewed · How we verify
NCT05299320
Postural Control in Covid-19
trial testing Neuromuscular fatigue and postural sway evaluation in COVID-19 in 56 participants. Completed in 20 June 2022.
10 June 2022
Quick facts
| Lead sponsor | Karamanoğlu Mehmetbey University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 56 |
| Start date | 2 March 2022 |
| Primary completion | 10 June 2022 |
| Estimated completion | 20 June 2022 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Neuromuscular fatigue and postural sway evaluation
Conditions studied
- COVID-19 — all drugs for COVID-19 →
- Performance — all drugs for Performance →
Sponsor
Karamanoğlu Mehmetbey University
Who can join
Adults 18 to 30, female only, with COVID-19 or Performance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was planned to investigate how much the anaerobic performance of individuals who experienced fatigue with Want (Wingate) affected their postural sway parameters.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05299320
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Karamanoğlu Mehmetbey University trials
Trials by the same sponsor.
- NCT07499297 — THE EFFECTS OF CIRCADIAN RHYTHM-BASED PROGRESSIVE RELAXATION EXERCISES IN HEMODIALYSIS PATIENTS · NA · not yet recruiting
- NCT07406607 — The Effect of Presence of Father in the Operating Room on Quality of Recovery of the Parturient · NA · recruiting
- NCT07302282 — The Effectiveness of Pain Neuroscience Education for Patients With Carpal Tunnel Syndrome · NA · recruiting
- NCT07377851 — Carbonic Anhydrase II Responses to Basketball-Specific High-Intensity Interval Training · NA · completed
- NCT07142577 — The Effect of Mandala Coloring on Mental Well-Being and Life Satisfaction in Elderly Individuals in Nursing Homes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05299320 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karamanoğlu Mehmetbey University
- Last refreshed: 26 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05299320.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing